Treatment of Spinal Muscular Atrophy using moxifloxacin - Banco de Patentes
Back Treatment of Spinal Muscular Atrophy using moxifloxacin
Treatment of Spinal Muscular Atrophy using moxifloxacin
Treatment of Spinal Muscular Atrophy using moxifloxacin
Universitat de València's researchers in collaboration with the INCLIVA Foundation have identified the use of a molecule as a new candidate drug for developing a new therapy for Spinal Muscular Atrophy (SMA), that increases significantly surviving motor neuron (SMN) protein levels in various cellular disease models.
INTELLECTUAL PROPERTY RIGHTS
The technology is patent application protected
Contacto:
Sección de Innovación y Valorización
Servicio de Transferencia e Innovación
Universitat de València
Avda. Blasco Ibáñez, 13, nivel 2
46010, Valencia
Tel: 96 386 40 61
e-mail: patentes.otri@uv.es